Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma
Cancer, 08/26/09
Agrawal S et al. – Adjuvant RT was associated with improved regional lymph node basin control compared with therapeutic lymphadenectomy (TL) alone in patients with high risk, clinically advanced, lymph node metastatic melanoma
Methods- 615 patients with clinically advanced, regional lymph node metastatic disease underwent TL
- Median f/u 5 y
- The actuarial 5 y regional lymph node basin control rate was 81%
- The number of positive lymph nodes, the number of lymph nodes removed, and the use of adjuvant RT were associated with improved regional control
- Tx-related morbidity, particularly lymphedema, was increased with the use of adjuvant RT and an inguinal site of lymph node metastases
- At last f/u, 268 patients were alive with actuarial 5 y distant metastasis-free survival (DMFS) and DSS rates of 40% and 48%, respectively
- DMFS and DSS were influenced by the number of positive lymph nodes and the number of lymph nodes removed
- DSS was influenced by primary tumor thickness and adjuvant RT
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
Clinical and Experimental Metastasis, 03/22/10
An Oncogenic Role for ETV1 in Melanoma
Cancer Research, 03/22/10
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Clinical Cancer Research, 03/16/10
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Successful Triple Combination Therapy of Disseminated Absidia corymbifera Infection in an Adolescent With Osteosarcoma
Journal of Pediatric Hematology/Oncology, 03/22/10
Successful Treatment of Life-threatening Candida Peritonitis in a Child With Abdominal Non-Hodgkin Lymphoma Using Efungumab and Amphotericin B Colloid Dispersion
Journal of Pediatric Hematology/Oncology, 03/22/10
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
Cancer Chemotherapy and Pharmacology, 03/22/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


